Clinical

The mental health of sick babies in hospital: Risks, vulnerabilities, and the impact of COVID-19

Hospitalisation for treatment of serious illness can place infants, and their families, at risk with respect to their mental health. Trauma responses are common, and optimal infant-parent relationship development may be disrupted. Significant additional environmental and psychosocial burdens were placed on this group in 2020 as a consequence of measures adopted to protect the community from COVID-19.

.

The RCH Neuroscience Advanced Clinical Imaging Service (NACIS)

Neuroscience Advanced Clinical Imaging Service (NACIS) is the translational clinical and research program embedded in the Neurosurgery Department at The Royal Children’s Hospital (RCH). Although officially established in January 2020, NACIS emerged from work since 2012 which was supported by a Clinical Paediatric Neurosurgery Research Fellowship from the RCH Foundation.

.

A Stepped Care Approach to Developmental Care – Improving intake processes for children referred with a developmental concern

A Stepped Care Approach to Developmental Care is a Royal Children’s Hospital Foundation funded project which aims to ensure that children referred with a developmental concern are seen by the right person in the right place at the right time.  To achieve this a new Allied Health centralised intake team apply a stepped approach that identifies the child’s needs and pathway. 

.

The Hopkins Symposium: Complex Movement Disorders – the Genesis of Contemporary Care

The Complex Movement Disorders program at the Royal Children’s Hospital commenced in 1997 and has evolved since then. It is currently funded by RCH Foundation and the fundraising efforts of A/Prof Andrew Kornberg’s Fly for the Kids event in 2017. The program allows coordinated multidisciplinary assessment and management of children with movement disorders and associated neurodevelopmental comorbidities.

.

Embedding Clinical Research Into Great Care: Introducing the Clinical Research Incubator

Advances in health and medical research are accelerating our understanding of disease mechanisms, and leading to new preventative interventions, diagnostic tools and novel therapeutic approaches that are transforming clinical care. Hence, there is an increasing need to better embed clinical research into clinical care delivered at the RCH and to support the development of individuals who are fluent in both clinical care and research.

.

COVID-19: An Update: What have we learnt over the last 12 months?

Never in the field of health was so much learned by so many in so few months.  This, the opening Grand Round for 2021 will recap the lessons from last year, take stock of where we are in February 2021, describe the complex situation with vaccines, and look to what the year might hold for the pandemic and children in Australia and countries around the world.  Topics will include: Why is COVID-19 less severe in children?  What is the role of schools in transmission and what is the impact of new variants?  Vaccines: who, when and how? The indirect effects of Covid: poverty and malnutrition, measles, loss of education, and child marriage.

.

“Bring in the Allies!” Allied Health, united in care

RCH is excited to be celebrating Allied Health Professionals Day on 14 October 2020. Allied Health Professionals Day first began in the UK in 2018 and has since become an international event to recognise and celebrate the Allied Health Professional community.

.

Practical and ethical challenges in treatment of paediatric neurogenetic disorders

There has in recent years been a rapid increase in the number and complexity of clinical trials and novel therapies for neurogenetic conditions. Many of these conditions are individually rare, but their impact upon affected children and their families may be very severe.  While the increasing awareness and availability of new treatments brings great hope and excitement for all involved in care of these children, it also presents significant challenges for clinicians and for patients and their families.

.

CAR T Cell Therapy for acute leukaemia: The RCH experience as the national paediatric referral centre

Chimeric Antigen Receptor (CAR) T cells have revolutionised treatment for patients with acute lymphoblastic leukaemia (ALL) where standard therapies have failed.  We reflect on our first 12 months as the first national paediatric referral centre providing CAR T cell treatment to children with relapsed or refractory ALL from Australia and New Zealand, and highlight the collective efforts and lessons for the hospital-wide CAR T cell team. 

.